BIIB vs ECVT · P/E 21, rev $9.89B vs rev $464.9M
Biogen Inc (BIIB) versus Ecovyst Inc (ECVT) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Ecovyst Inc (ECVT) is a specialty chemicals company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ECVT revenue for 2026-06-30 was $464.9M. Net income was $12.2M. ECVT currently screens at market cap $892.2M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ECVT currently screens at market cap $892.2M.
Not investment advice. Open the BIIB and ECVT stock pages for the full models.
Not investment advice.